Early phase trial of ibrutinib for chronic lymphocytic leukaemia

How malignant cells in patients with CLL escape T-cell recognition

Clinical trials for rare tumour types

First line treatment against metastatic breast cancer

Effects of lapatinib and trastuzumab on progression free survival

President's overview of ASCO 2012

Afatinib delays progression of advanced lung adenocarcinomas

Routine molecular testing of non-small cell lung cancers in community settings

Increased progression-free survival in advanced lung cancer with afatinib

Bendamustine regimen more effective for lymphoma than standard CHOP

Problems in the structure of clinical trials

Prognostic biomarkers and next generation genomic sequencing